SK284520B6 - Rýchlo sa rozpúšťajúci lisovaný ribavirínový prostriedok a spôsob jeho prípravy - Google Patents

Rýchlo sa rozpúšťajúci lisovaný ribavirínový prostriedok a spôsob jeho prípravy Download PDF

Info

Publication number
SK284520B6
SK284520B6 SK894-2000A SK8942000A SK284520B6 SK 284520 B6 SK284520 B6 SK 284520B6 SK 8942000 A SK8942000 A SK 8942000A SK 284520 B6 SK284520 B6 SK 284520B6
Authority
SK
Slovakia
Prior art keywords
ribavirin
range
effective amount
compressed
composition according
Prior art date
Application number
SK894-2000A
Other languages
English (en)
Slovak (sk)
Other versions
SK8942000A3 (en
Inventor
Stephen M. Liebowitz
Elliot I. Stupak
Imtiaz A. Chaudry
Winston A. Vadino
Frank E. Bowen
Original Assignee
Schering Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27130673&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SK284520(B6) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/997,172 external-priority patent/US5914128A/en
Priority claimed from US08/997,169 external-priority patent/US5916594A/en
Application filed by Schering Corporation filed Critical Schering Corporation
Publication of SK8942000A3 publication Critical patent/SK8942000A3/sk
Publication of SK284520B6 publication Critical patent/SK284520B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4833—Encapsulating processes; Filling of capsules

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SK894-2000A 1997-12-22 1998-12-21 Rýchlo sa rozpúšťajúci lisovaný ribavirínový prostriedok a spôsob jeho prípravy SK284520B6 (sk)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/997,172 US5914128A (en) 1997-12-22 1997-12-22 Orally administrable solid dosage form
US08/997,169 US5916594A (en) 1997-12-22 1997-12-22 Process of making solid ribavirin dosage forms
PCT/US1998/026222 WO1999032128A1 (en) 1997-12-22 1998-12-21 Orally administrable solid ribavirin dosage forms and process for making them

Publications (2)

Publication Number Publication Date
SK8942000A3 SK8942000A3 (en) 2001-04-09
SK284520B6 true SK284520B6 (sk) 2005-05-05

Family

ID=27130673

Family Applications (1)

Application Number Title Priority Date Filing Date
SK894-2000A SK284520B6 (sk) 1997-12-22 1998-12-21 Rýchlo sa rozpúšťajúci lisovaný ribavirínový prostriedok a spôsob jeho prípravy

Country Status (27)

Country Link
US (3) US6337090B1 (ja)
EP (2) EP1321147A1 (ja)
JP (2) JP2001526234A (ja)
KR (1) KR100575389B1 (ja)
CN (1) CN1155388C (ja)
AR (1) AR008977A1 (ja)
AT (1) ATE234103T1 (ja)
AU (1) AU762826B2 (ja)
BR (1) BR9814367A (ja)
CA (4) CA2365412C (ja)
CO (1) CO4970774A1 (ja)
DE (1) DE69812094T2 (ja)
DK (1) DK0991415T3 (ja)
ES (1) ES2191987T3 (ja)
HK (1) HK1034674A1 (ja)
HU (1) HUP0100433A3 (ja)
IL (1) IL136549A (ja)
MY (1) MY119656A (ja)
NO (1) NO20003234L (ja)
NZ (1) NZ504994A (ja)
PE (1) PE20000066A1 (ja)
PL (1) PL190267B1 (ja)
PT (1) PT991415E (ja)
SK (1) SK284520B6 (ja)
TW (1) TW575436B (ja)
WO (1) WO1999032128A1 (ja)
ZA (1) ZA9811726B (ja)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001526234A (ja) * 1997-12-22 2001-12-18 シェーリング コーポレイション 経口投与が可能な固形リバビリン投薬の形態およびそれらの製造プロセス
US6793934B1 (en) * 1999-12-08 2004-09-21 Shire Laboratories, Inc. Solid oral dosage form
JP2004500207A (ja) * 2000-03-06 2004-01-08 ティシューリンク・メディカル・インコーポレーテッド 流体配給システム及び電気外科用器具コントローラ
US6720000B2 (en) * 2001-03-19 2004-04-13 Three Rivers Pharmaceutical, Llc Process for producing wet ribavirin pellets
KR20030020137A (ko) * 2001-09-03 2003-03-08 진양제약주식회사 리바비린 건조시럽제
BR0213861A (pt) * 2001-11-02 2004-12-21 Sandoz Ag Processo para a preparação de composições de ribavirina de carga elevada, de dissolução rápida
DE10227148A1 (de) * 2002-06-18 2004-01-08 Biopartners Gmbh Verwendung von Ribavirin zur Herstellung einer pharmazeutischen Zusammensetzung gegen Bunyaviridae
US7538094B2 (en) * 2002-09-19 2009-05-26 Three Rivers Pharmacueticals, Llc Composition containing ribavirin and use thereof
US20040142903A1 (en) * 2003-01-16 2004-07-22 Par Pharmaceutical Inc. Bioavailable fenofibrate compositions, methods for treating hyperlipidemia and hypercholesterolemia and processes for the preparation of such compositions
WO2004084796A2 (en) * 2003-03-28 2004-10-07 Pharmasset Ltd. Compounds for the treatment of flaviviridae infections
MX2007002784A (es) * 2004-09-09 2009-02-12 Bayer Animal Health Gmbh Composición farmacéutica en forma de dosificación sólida soluble en agua.
US7723310B2 (en) * 2004-10-18 2010-05-25 Three Rivers Pharmaceuticals, Llc Large dose ribavirin formulations
EP1917301B1 (en) * 2005-08-05 2014-04-23 3M Innovative Properties Company Compositions exhibiting improved flowability
EP2054076A2 (en) * 2006-08-21 2009-05-06 United Therapeutics Corporation Combination therapy for treatment of viral infections
WO2009142852A2 (en) * 2008-05-22 2009-11-26 3M Innovative Properties Company Process for manufacturing flowable powder drug compositions
WO2009158300A1 (en) * 2008-06-26 2009-12-30 3M Innovative Properties Company Dry powder pharmaceutical compositions for pulmonary administration, and methods of manufacturing thereof
US9861580B2 (en) * 2008-07-02 2018-01-09 3M Innovative Properties Company Method of making a dry powder pharmaceutical composition
EP2295037A1 (en) 2009-09-11 2011-03-16 Ratiopharm GmbH Pharmaceutical formulation containing Ribavirin
US10363453B2 (en) 2011-02-07 2019-07-30 New Balance Athletics, Inc. Systems and methods for monitoring athletic and physiological performance
CA2752008A1 (en) 2011-09-13 2013-03-13 Universite De Montreal Combination therapy using ribavirin as elf4e inhibitor
CN106389363A (zh) * 2016-10-18 2017-02-15 广东肇庆星湖生物科技股份有限公司 一种利巴韦林口服固体制剂及其制备方法

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1228029C2 (de) * 1964-05-09 1973-05-17 Merck Ag E Verfahren zur Herstellung von Tabletten durch Pressen von Pulvergemischen ohne vorhergehende Granulation
US3490742A (en) * 1966-01-14 1970-01-20 Staley Mfg Co A E Compressed tablets
US3622677A (en) * 1969-07-07 1971-11-23 Staley Mfg Co A E Compressed tablets containing compacted starch as binder-disintegrant ingredient
US4211771A (en) * 1971-06-01 1980-07-08 Robins Ronald K Treatment of human viral diseases with 1-B-D-ribofuranosyl-1,2,4-triazole-3-carboxamide
DE2735600A1 (de) * 1977-08-06 1979-02-15 Dynamit Nobel Ag Verfahren zur herstellung von phthalid
JPS57146593A (en) * 1981-03-09 1982-09-10 Ajinomoto Co Inc Preparation of ribofuranosyltriazole derivative
US4609675A (en) * 1984-08-17 1986-09-02 The Upjohn Company Stable, high dose, high bulk density ibuprofen granulations for tablet and capsule manufacturing
US4681765A (en) * 1984-09-13 1987-07-21 American Home Products Corporation Rapid releasing triamterene containing gelatin capsule dosage forms for once daily antihypertensive use
US5077279A (en) * 1986-05-01 1991-12-31 University Of Georgia Research Foundation, Inc. 3'-azido-2',3'-dideoxy-5-methylcytidine anti-viral composition
US5084445A (en) * 1986-05-01 1992-01-28 University Of Georgia Research Foundation, Inc. 3'-azido-2',3'-dideoxy-5-methylcytidine
GB8628359D0 (en) * 1986-11-27 1986-12-31 Zyma Sa Galenical formulation
JPS63216820A (ja) * 1987-03-05 1988-09-09 Chugai Pharmaceut Co Ltd 抗ウイルス剤
GB8800276D0 (en) * 1988-01-07 1988-02-10 Univ Liverpool Medical treatment
US5030447A (en) * 1988-03-31 1991-07-09 E. R. Squibb & Sons, Inc. Pharmaceutical compositions having good stability
US5192788A (en) * 1988-05-23 1993-03-09 Georgia State University Foundation, Inc. Porphyrin antiviral compositions
US5109016A (en) * 1988-05-23 1992-04-28 Georgia State University Foundation, Inc. Method for inhibiting infection or replication of human immunodeficiency virus with porphyrin and phthalocyanine antiviral compositions
US5122517A (en) * 1988-06-10 1992-06-16 Regents Of The University Of Minnesota Antiviral combination comprising nucleoside analogs
NZ229453A (en) * 1988-06-10 1991-08-27 Univ Minnesota & Southern Rese A pharmaceutical composition containing purine derivatives with nucleosides such as azt, as antiviral agents
JP2908844B2 (ja) * 1990-06-29 1999-06-21 ヤマサ醤油株式会社 抗ウイルス剤
DE69324244T2 (de) * 1992-01-06 1999-09-30 Wellcome Found Therapeutische nukleoside der 2',3'-dideoxy-3'-fluor -purin reihe
US5869097A (en) * 1992-11-02 1999-02-09 Alza Corporation Method of therapy comprising an osmotic caplet
US5358721A (en) * 1992-12-04 1994-10-25 Alza Corporation Antiviral therapy
JPH06298665A (ja) * 1993-04-14 1994-10-25 Toray Ind Inc 抗ウイルス剤
US5506248A (en) * 1993-08-02 1996-04-09 Bristol-Myers Squibb Company Pharmaceutical compositions having good dissolution properties
US5492692A (en) * 1993-08-17 1996-02-20 University Of Kentucky Research Foundation Coated products with potent anti-HIV and antimicrobial properties
US5370878A (en) * 1993-09-30 1994-12-06 Hallmark Pharmaceuticals, Inc. Method for preparing a direct compression granulated acetaminophen composition
US5605889A (en) * 1994-04-29 1997-02-25 Pfizer Inc. Method of administering azithromycin
CA2135669A1 (en) 1994-11-10 1996-05-11 Nils O. Johannesson Ribavirin as hepato (liver) protecting agent
US5948438A (en) * 1995-01-09 1999-09-07 Edward Mendell Co., Inc. Pharmaceutical formulations having improved disintegration and/or absorptivity
US6106865A (en) * 1995-01-09 2000-08-22 Edward Mendell Co., Inc. Pharmaceutical excipient having improved compressibility
IL139728A (en) * 1995-01-09 2003-06-24 Penwest Pharmaceuticals Compan Aqueous slurry composition containing microcrystalline cellulose for preparing a pharmaceutical excipient
US5585115A (en) * 1995-01-09 1996-12-17 Edward H. Mendell Co., Inc. Pharmaceutical excipient having improved compressability
JP4105762B2 (ja) * 1995-02-28 2008-06-25 アベンティス・ファーマスーティカルズ・インコーポレイテツド ピペリジノアルカノール化合物のための医薬組成物
US6387365B1 (en) * 1995-05-19 2002-05-14 Schering Corporation Combination therapy for chronic hepatitis C infection
US5733578A (en) * 1995-11-15 1998-03-31 Edward Mendell Co., Inc. Directly compressible high load acetaminophen formulations
US5723589A (en) * 1995-12-21 1998-03-03 Icn Pharmaceuticals Carbohydrate conjugated bio-active compounds
IT1282650B1 (it) * 1996-02-19 1998-03-31 Jagotec Ag Compressa farmaceutica,caratterizzata da elevato aumento di volume a contatto con liquidi biologici
US6172046B1 (en) * 1997-09-21 2001-01-09 Schering Corporation Combination therapy for eradicating detectable HCV-RNA in patients having chronic Hepatitis C infection
US5916594A (en) * 1997-12-22 1999-06-29 Schering Corporation Process of making solid ribavirin dosage forms
JP2001526234A (ja) * 1997-12-22 2001-12-18 シェーリング コーポレイション 経口投与が可能な固形リバビリン投薬の形態およびそれらの製造プロセス
US5914128A (en) * 1997-12-22 1999-06-22 Schering Corporation Orally administrable solid dosage form

Also Published As

Publication number Publication date
CA2365412A1 (en) 1999-07-01
WO1999032128A1 (en) 1999-07-01
MY119656A (en) 2005-06-30
CN1155388C (zh) 2004-06-30
JP2001526234A (ja) 2001-12-18
DE69812094T2 (de) 2003-12-24
PL341230A1 (en) 2001-03-26
CA2323849A1 (en) 1999-07-01
AU762826B2 (en) 2003-07-03
CO4970774A1 (es) 2000-11-07
EP1321147A1 (en) 2003-06-25
CA2323849C (en) 2002-06-11
CA2287056C (en) 2000-08-15
ATE234103T1 (de) 2003-03-15
DE69812094D1 (de) 2003-04-17
CA2300452C (en) 2000-11-28
NO20003234L (no) 2000-08-21
HUP0100433A3 (en) 2003-01-28
PE20000066A1 (es) 2000-02-09
TW575436B (en) 2004-02-11
KR20010033441A (ko) 2001-04-25
ES2191987T3 (es) 2003-09-16
IL136549A0 (en) 2001-06-14
SK8942000A3 (en) 2001-04-09
CA2365412C (en) 2002-09-17
DK0991415T3 (da) 2003-06-16
HK1034674A1 (en) 2001-11-02
JP2006083189A (ja) 2006-03-30
NZ504994A (en) 2002-10-25
ZA9811726B (en) 1999-06-21
AR008977A1 (es) 2000-03-08
HUP0100433A2 (hu) 2001-12-28
EP0991415A1 (en) 2000-04-12
AU2199199A (en) 1999-07-12
US6337090B1 (en) 2002-01-08
CN1283117A (zh) 2001-02-07
BR9814367A (pt) 2000-10-17
EP0991415B1 (en) 2003-03-12
PT991415E (pt) 2003-06-30
PL190267B1 (pl) 2005-11-30
CA2300452A1 (en) 1999-07-01
KR100575389B1 (ko) 2006-05-03
NO20003234D0 (no) 2000-06-21
US6051252A (en) 2000-04-18
US6335032B1 (en) 2002-01-01
IL136549A (en) 2005-05-17
CA2287056A1 (en) 1999-07-01

Similar Documents

Publication Publication Date Title
SK284520B6 (sk) Rýchlo sa rozpúšťajúci lisovaný ribavirínový prostriedok a spôsob jeho prípravy
JP6797980B2 (ja) ルカパリブの高投与力価錠剤
KR100634253B1 (ko) 초강력 붕해제를 사용한 고속-용해 에파비렌즈 캡슐 또는정제 및 그의 제조 방법
JP3563036B2 (ja) セレコキシブ組成物
JP4334616B2 (ja) 湿式粒状化による投与単位体を製造する方法
CN101416949A (zh) 雌激素药物药用组合物
BG64886B1 (bg) Фармацевтичен препарат, съдържащ клодронат като активен компонент и силикатизирана микрокристална целулоза като пълнител
WO2008057266A2 (en) Dry granulation binders, products, and use thereof
US5914128A (en) Orally administrable solid dosage form
JP2013533881A (ja) バノキセリンを含有する医薬組成物
US5916594A (en) Process of making solid ribavirin dosage forms
JPH1121236A (ja) ロキソプロフェン・ナトリウム固形製剤
KR20110104059A (ko) 경구 생체이용률이 낮은 화합물의 예비압축된 신속-붕해 제형
AU742943B2 (en) Orally administrable solid ribavirin dosage forms and process for making them
PL216542B1 (pl) Sposób wytwarzania stabilnej kompozycji orlistatu w postaci kapsułkowanego proszku
CZ20002303A3 (cs) Perorálně podávatelné pevné ribavirinové dávkové formy a způsob jejich přípravy
JPH10226644A (ja) 医薬組成物
JP2702325B2 (ja) 顆粒状カルシウム組成物及びそれからなる錠剤
MXPA00006188A (en) Orally administrable solid ribavirin dosage forms and process for making them
JP2019014700A (ja) エゼチミブ含有口腔内崩壊錠及びその製造方法
JPWO2003072095A1 (ja) ソファルコン含有組成物

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20111221